SYNTEC OPTICS HOLDINGS INC (OPTX)
US87169M1053 - Common Stock
OPTX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 126 industry peers in the Electronic Equipment, Instruments & Components industry. OPTX has a bad profitability rating. Also its financial health evaluation is rather negative. OPTX is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year OPTX was profitable.
In the past year OPTX had a positive cash flow from operations.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.79%, OPTX is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 8.54%, OPTX is in the better half of the industry, outperforming 71.20% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.38%, OPTX is in line with its industry, outperforming 53.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.79% | ||
| ROE | 8.54% | ||
| ROIC | 1.38% |
ROA(3y)5.81%
ROA(5y)N/A
ROE(3y)14.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 2.05%, OPTX is in line with its industry, outperforming 57.60% of the companies in the same industry.
The Operating Margin of OPTX (0.79%) is comparable to the rest of the industry.
OPTX's Gross Margin of 24.99% is in line compared to the rest of the industry. OPTX outperforms 41.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.79% | ||
| PM (TTM) | 2.05% | ||
| GM | 24.99% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
OPTX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
OPTX has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, OPTX has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 7.70 indicates that OPTX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.70, OPTX belongs to the top of the industry, outperforming 85.60% of the companies in the same industry.
OPTX has a Debt/Equity ratio of 0.88. This is a neutral value indicating OPTX is somewhat dependend on debt financing.
OPTX has a Debt to Equity ratio of 0.88. This is amonst the worse of the industry: OPTX underperforms 86.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 7.7 |
ROIC/WACC0.13
WACC10.34%
2.3 Liquidity
OPTX has a Current Ratio of 1.34. This is a normal value and indicates that OPTX is financially healthy and should not expect problems in meeting its short term obligations.
OPTX has a Current ratio of 1.34. This is amonst the worse of the industry: OPTX underperforms 87.20% of its industry peers.
A Quick Ratio of 0.63 indicates that OPTX may have some problems paying its short term obligations.
The Quick ratio of OPTX (0.63) is worse than 92.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.34 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
OPTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 218.07%, which is quite impressive.
The Revenue has been growing slightly by 5.75% in the past year.
EPS 1Y (TTM)218.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)5.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 88.25, the valuation of OPTX can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as OPTX.
OPTX is valuated expensively when we compare the Price/Earnings ratio to 28.77, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 88.25 | ||
| Fwd PE | N/A |
4.2 Price Multiples
OPTX's Enterprise Value to EBITDA is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 42.38 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
OPTX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SYNTEC OPTICS HOLDINGS INC
NASDAQ:OPTX (12/17/2024, 9:20:47 PM)
Premarket: 3.05 -0.48 (-13.6%)3.53
+1.75 (+98.31%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap129.52M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 88.25 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.79% | ||
| ROE | 8.54% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 0.79% | ||
| PM (TTM) | 2.05% | ||
| GM | 24.99% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.34 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)218.07%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.75%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y